These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 426883)

  • 1. Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis. Comparison of two dosage schedules of choline magnesium trisalicylate.
    Cassell S; Furst D; Dromgoole S; Paulus H
    Arthritis Rheum; 1979 Apr; 22(4):384-8. PubMed ID: 426883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline magnesium trisalicylate: comparative pharmacokinetic study of once-daily and twice-daily dosages.
    Levitt MJ; Kann J
    J Pharm Sci; 1984 Jul; 73(7):977-9. PubMed ID: 6470965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable serum salicylate concentrations from choline magnesium trisalicylate, aspirin, and buffered aspirin in rheumatoid arthritis.
    Binus MH; Lyon JA; Nicholas JL
    Arthritis Rheum; 1982 Apr; 25(4):464-6. PubMed ID: 7073776
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of a non-acetylated salicylate, choline magnesium trisalicylate, in the treatment of rheumatoid arthritis.
    Rothwell KG
    J Int Med Res; 1983; 11(6):343-8. PubMed ID: 6360749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of choline magnesium trisalicylate in rheumatoid arthritis.
    Mody GM; Naidoo PD; Singh TG
    S Afr Med J; 1983 Aug; 64(6):195-6. PubMed ID: 6348967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily treatment of rheumatoid arthritis with choline magnesium trisalicylate.
    Mann CC; Boyer JT
    Clin Ther; 1984; 6(2):170-7. PubMed ID: 6705011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for reaching therapeutic salicylate levels in patients with rheumatoid arthritis using standardized dosing regimens.
    Furst DE; Blocka K; Cassell S; Dromgoole S; Harris ER; Hirschberg JM; Josephson N; Rupp PA; Paulus HE; Trimble RB
    J Rheumatol; 1987 Apr; 14(2):342-7. PubMed ID: 3599003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic comparison of choline magnesium trisalicylate and soluble aspirin.
    Helliwell M; Gibson T; Berry D; Volans G
    Br J Rheumatol; 1984 Nov; 23(4):288-91. PubMed ID: 6487934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline magnesium trisalicylate--a new formulation of salicylate.
    Klemp P; Meyers OL
    S Afr Med J; 1982 Dec; 62(25):927-8. PubMed ID: 7147131
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of choline magnesium trisalicylate and acetylsalicylic acid in patients with rheumatoid arthritis.
    Le Gallez P; Bird HA; Wright V
    Curr Med Res Opin; 1990; 12(2):71-5. PubMed ID: 2202551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis.
    Tracy TS; Krohn K; Jones DR; Bradley JD; Hall SD; Brater DC
    Eur J Clin Pharmacol; 1992; 42(2):121-5. PubMed ID: 1618240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis.
    Blechman WJ; Lechner BL
    Rheumatol Rehabil; 1979 May; 18(2):119-24. PubMed ID: 377449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative plasma salicylate and urine salicylurate levels following administration of aspirin, magnesium salicylate, and choline magnesium trisalicylate.
    Mason WD
    J Pharm Sci; 1980 Nov; 69(11):1355-6. PubMed ID: 7452472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis.
    Ehrlich GE; Miller SB; Zeiders RS
    Rheumatol Rehabil; 1980 Feb; 19(1):30-41. PubMed ID: 7361026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritis.
    Furst DE; Blocka K; Cassell S; Harris ER; Hirschberg JM; Josephson N; Lachenbruch PA; Trimble RB; Paulus HE
    Arthritis Rheum; 1987 Feb; 30(2):146-54. PubMed ID: 3548732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis.
    Pachman LM; Olufs R; Procknal JA; Levy G
    Arthritis Rheum; 1979 Aug; 22(8):826-31. PubMed ID: 465097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis.
    Furst DE; Sarkissian E; Blocka K; Cassell S; Dromgoole S; Harris ER; Hirschberg JM; Josephson N; Paulus HE
    Arthritis Rheum; 1987 Oct; 30(10):1157-61. PubMed ID: 3675660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antacid and ascorbic acid on serum salicylate concentration.
    Hansten PD; Hayton WL
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):326-31. PubMed ID: 7400368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity.
    Cersosimo RJ; Matthews SJ
    Drug Intell Clin Pharm; 1987; 21(7-8):621-5. PubMed ID: 3301251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.